Scarica l'app Stockscreener
4.24
0.93%
-0.04
Dopo l'orario di chiusura:
4.24
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché RCEL Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$4.28
Aprire:
$4.32
Volume 24 ore:
111.10K
Relative Volume:
0.50
Capitalizzazione di mercato:
$130.49M
Reddito:
$71.61M
Utile/perdita netta:
$-48.59M
Rapporto P/E:
-2.4215
EPS:
-1.751
Flusso di cassa netto:
$-32.88M
1 W Prestazione:
-2.08%
1M Prestazione:
+14.29%
6M Prestazione:
+21.14%
1 anno Prestazione:
-53.96%
Intervallo 1D:
$4.175
$4.36
Intervallo di 1 settimana:
$4.11
$4.565
Portata 52W:
$3.22
$9.845
Avita Medical Inc Stock (RCEL) Company Profile
Nome
Avita Medical Inc
Settore
Industria
Telefono
661-568-1317
Indirizzo
28159 AVENUE STANFORD, VALENCIA, CA
Compare RCEL vs ABT, SYK, MDT, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
RCEL
Avita Medical Inc
|
4.24 | 131.72M | 71.61M | -48.59M | -32.88M | -1.751 |
ABT
Abbott Laboratories
|
87.17 | 152.48B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
295.25 | 111.40B | 25.27B | 3.34B | 4.57B | 8.6358 |
MDT
Medtronic Plc
|
77.79 | 100.53B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
55.98 | 84.50B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
82.91 | 48.04B | 6.30B | 1.07B | 1.34B | 1.8406 |
Avita Medical Inc Stock (RCEL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-03-05 | Iniziato | Northland Capital | Outperform |
| 2025-11-20 | Aggiornamento | BTIG Research | Sell → Neutral |
| 2025-08-08 | Downgrade | BTIG Research | Neutral → Sell |
| 2024-12-24 | Iniziato | D. Boral Capital | Buy |
| 2024-04-11 | Downgrade | BTIG Research | Buy → Neutral |
| 2023-06-27 | Iniziato | Cantor Fitzgerald | Overweight |
| 2021-03-02 | Iniziato | Piper Sandler | Overweight |
| 2020-08-27 | Iniziato | BofA Securities | Buy |
| 2020-04-21 | Iniziato | Oppenheimer | Outperform |
| 2020-03-03 | Iniziato | BTIG Research | Buy |
Mostra tutto
Avita Medical Inc Borsa (RCEL) Ultime notizie
AVITA Medical appoints Cary Vance as permanent CEO - MSN
AVITA Medical Appoints Cary Vance as Permanent CEO and Jan Stern Reed as Board Chair to Drive Growth in Acute Wound Care Solutions - Minichart
Avita Medical (NASDAQ:RCEL) Stock Rating Lowered by Wall Street Zen - MarketBeat
AVITA Medical wins BARDA contract worth up to $25.5M - MSN
Avita Medical Names Cary Vance Permanent CEO, Reshapes Board - TipRanks
Cary Vance becomes AVITA Medical (NASDAQ: RCEL) CEO as Board elevates Jan Stern Reed to Chair - Stock Titan
AVITA Medical Names Cary Vance as Chief Executive Officer - Investing News Network
AVITA Medical names Cary Vance as permanent CEO - Investing.com
AVITA Medical names Cary Vance as permanent CEO By Investing.com - Investing.com Canada
After 6 months as interim CEO, Cary Vance gets AVITA's top job - Stock Titan
RCEL Stock Price, Quote & Chart | AVITA MEDICAL INC (NASDAQ:RCEL) - ChartMill
Avita Medical (RCEL) Secures Certification for Recell Go in Aust - GuruFocus
AVITA Medical Announces TGA Certification in Australia and Medsafe WAND Listing in New Zealand for RECELL GO - Investing News Network
AVITA Medical gains regulatory clearance for RECELL GO in Australia By Investing.com - Investing.com Canada
Burn care tool cleared for sale in Australia and New Zealand - Stock Titan
Why this ASX healthcare stock is surging while the market sinks on Middle East fears - MSN
AVITA Medical appoints Cary Vance as interim CEO - MSN
Avita Medical (RCEL) upgraded to buy: Here's what you should know - MSN
Avita signals revenue recovery with $70M–$74M 2025 outlook following reimbursement clarity - MSN
AVITA Medical to Announce First Quarter 2026 Financial Results - Investing News Network
AVITA Medical schedules May 14 earnings release, 1:30 p.m. call - Stock Titan
Guess which ASX All Ords healthcare share is jumping 11% on big European news - MSN
Is Avita Medical (RCEL) stock under bearish pressure | Q4 2025: Below ExpectationsCyclicality - Cổng thông tin điện tử tỉnh Tây Ninh
Board pay, director equity and warrants on AVITA Medical (NASDAQ: RCEL) 2026 ballot - Stock Titan
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AVITA Medical ... - Bluefield Daily Telegraph
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AVITA Medical Inc.RCEL - ChartMill
Is Avita Medical (RCEL) stock overpriced relative to performance (Trades Higher) 2026-04-18 - Cổng thông tin điện tử Tỉnh Sơn La
TD Cowen Maintains Avita Medical(RCEL.US) With Buy Rating, Maintains Target Price $5.5 - 富途牛牛
ALERT: Price-sensitive ASX Announcement for AVH - intelligentinvestor.com.au
Avita Medical Inc Azioni (RCEL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.41%
0.93%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):